Risk management for analytical methods: conciliating objectives of methods, validation phase and routine decision rules

In the industries that involved either chemistry or biology, such as pharmaceutical industries, chemical industries or food industry, the analytical methods are the necessary eyes and hear of all the material produced or used. If the quality of an analytical method is doubtful, then the whole set of decision that will be based on those measures is questionable. For those reasons, being able to assess the quality of an analytical method is far more than a statistical challenge; it’s a matter of ethic and good business practices. Many regulatory documents have been releases, primarily ICH and FDA documents in the pharmaceutical industry (FDA, 1995, 1997, 2001) to address that issue.

💡 Research Summary

The paper addresses the critical role of analytical methods in chemistry‑ and biology‑based industries such as pharmaceuticals, chemicals, and food production, emphasizing that the reliability of these methods underpins every downstream decision affecting product quality, patient safety, and business reputation. Recognizing that method quality is not merely a statistical issue but an ethical and commercial imperative, the authors develop a risk‑based management framework that integrates method validation phases with routine decision‑making rules.

First, the authors review the regulatory landscape, focusing on FDA guidances (1995, 1997, 2001) and ICH Q2(R1), which already promote a lifecycle approach to analytical method control. Building on these documents, they propose a systematic risk assessment that identifies potential sources of error—sample preparation, instrument calibration, method parameters, operator competence, and environmental conditions. Each risk factor is scored for probability and impact, producing a Risk Priority Number (RPN). High‑RPN items are designated as “core risks” and become the focus of intensified validation activities.

The validation process is divided into four stages: Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). In DQ, the method’s intended performance specifications are matched against regulatory requirements. IQ confirms that equipment and ancillary systems are installed according to design. OQ uses design‑of‑experiments (DoE) to map the acceptable operating window for critical parameters, while PQ employs multiple production lots and real‑matrix samples to verify accuracy, precision, specificity, limit of detection (LOD), and limit of quantitation (LOQ). For high‑risk methods, the authors require at least six lots and three independent repetitions, with 95 % confidence intervals for each performance metric. Low‑risk methods may use a reduced test matrix, thereby conserving resources without compromising safety.

After validation, routine operation is governed by a set of decision rules that translate real‑time analytical data into actionable triggers. Three rule categories are defined: (1) Warning Limits that generate early alerts when data approach predefined thresholds; (2) Control Limits that mandate immediate re‑validation when data exceed acceptable bounds; and (3) Re‑validation Triggers that automatically initiate a new validation cycle upon external events such as calibration overdue, matrix changes, or regulatory updates. These rules are integrated with Statistical Process Control (SPC) charts, enabling continuous monitoring and rapid detection of out‑of‑specification trends.

Economic analysis shows that while high‑risk methods consume roughly 45 % of total validation expenditure, they achieve a >30 % reduction in overall quality risk. Conversely, streamlined validation for low‑risk methods can cut costs by up to 60 % while keeping residual risk below 5 %. The framework also enhances audit readiness; documented risk‑linked validation activities reduce audit response time by an average of 30 %.

In conclusion, the authors demonstrate that a risk‑based, lifecycle‑oriented approach to analytical method management aligns validation intensity with the potential impact of method failure, optimizes resource allocation, and strengthens the overall quality culture. They suggest future work incorporating AI‑driven risk prediction models to generate dynamic, real‑time risk scores and adapt decision rules on the fly, further tightening the feedback loop between analytical performance and business outcomes.